Pretreatment with FK506 improves survival rate and gas exchange in canine model of acute lung injury

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 1, 2001, Pages 79-84

  Koshika, T ^a   Ishizaka, A ^a   Nagatomi, I ^a   Sudo, Y ^a   Hasegawa, N ^a   Goto, T ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; LK 948; METHYLPREDNISOLONE; PHORBOL 13 ACETATE 12 MYRISTATE; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; HYPOTENSION; HYPOXEMIA; LUNG GAS EXCHANGE; LUNG INJURY; LUNG VASCULAR RESISTANCE; LUNG WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SEPTIC SHOCK; SURVIVAL RATE;

EID: 0035156959     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.1.9906111     Document Type: Article

References (28)

1. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer
2. New approaches to the immunotherapy of cancer using interleukin-2: NIH conference
3. Immunotherapy of murine sarcomas using lymphokine activated killer cells: Optimization of the schedule and route of administration of recombinant interleukin-2
4. Increase of rat pulmonary microvascular permeability to albumin by recombinant interleukin-2
5. Prevention of interleukin 2-induced acute lung injury in guinea pigs by pentoxifylline
6. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock
7. Haemodynamic effects induced by intravenous administration of high doses of r-Met Hu IL-2 [ala-125] in patients with advanced cancer
8. Two types of septic shock classified by the plasma levels of cytokines and endotoxin
9. FK506: Historical perspectives
10. Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines and neutrophil infiltration after severe liver ischemia
11. Lung vascular injury after Escherichia coli endotoxin and phorbol myristate acetate infusion in dogs
12. IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells
13. Tumor necrosis factor-alpha mediates acid aspiration-induced systemic organ injury
14. Interleukin-2-induced lung injury: The role of complement
15. Locally produced tumor necrosis factor-alpha mediates interleukin-2-induced lung injury
16. FK506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro
17. Effects of an immunosuppressant, FK506, on interleukin-1 alpha production by human macrophages and a macrophage-like cell line, U937
18. Pulmonary edema after Escherichia coli peritonitis correlates with thiobarbituric-acid-reactive materials in bronchoalveolar lavage fluid
19. Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs
20. Augmentation of endotoxin-induced pulmonary responses by mononuclear cell phagocytosis in the reticuloendothelial system
21. Heat-killed Corynebacterium parvum enhances endotoxin lung injury with increased TNF production in guinea pigs
22. Inhibition by FK506 of formyl peptide-induced neutrophil activation and associated protein synthesis
23. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: Modulating effects of FK506 and cyclosporine
24. Partial inhibition of human neutrophil activation by FK506 at supratherapeutic concentrations
25. Attenuation of permeability lung injury after phorbol myristate acetate by verapamil and OKY-046
26. Attenuation of the pulmonary vascular response to endotoxin by a thromboxane synthesis inhibitor (UK-38485) in unanesthetized sheep
27. Role of circulating blood components and thromboxane in anaphylactic vasoconstriction in isolated canine lungs
28. Cyclosporine A enhances platelet aggregation